The London healthtech startup secured backing from Balderton and Pentland to scale manufacturing and regulatory pathways for its continuous glucose monitor.
"During their time at Imperial, they worked in one of the pioneering research groups that invented modern glucose strip technology. Their combined expertise in electrochemistry, biosensing, and medical device engineering laid the foundation for Sava’s next-generation biosensor platform."
The funding will support international expansion, team growth, and product line development for the cocoa-free chocolate maker.
"We're delighted to conclude this funding round, which provides us with extra resources to continue on our mission and deliver a sustainable and affordable alternative to chocolate. We're grateful that industry specialists such as Oetker recognise the need and opportunity, and have chosen Win-Win for their investment."
The financing comprises £13m in equity and a £100m debt facility from Crédit Agricole CIB.
"Sunsave was founded in 2022 with a mission to make solar and battery storage accessible to all UK households. Since launch, our £0 upfront subscription has seen rapid adoption, helping homes save hundreds of pounds on their energy bills and make a real difference to their finances. This £113M fundraise is a significant milestone in our journey – it will let us meet rapidly growing demand, launch new products, and give customers peace of mind that we’ll be here to support them for the long term."